Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketogenic Diet in Polycystic Kidney Disease
NCT06325644Recruiting
- Sponsor
- The Ohio State University
- Start
- Jun 2024
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Open-label, single-arm trial in polycystic kidney disease (PKD), sponsored by The Ohio State University. Primary endpoints: Finger Stick Beta-Hydroxybutyrate at 52 weeks and Finger Stick Glucose at 52 weeks. Started Jun 2024; status: recruiting.
02
Conditions
polycystic kidney disease (PKD)
Beyond the preview
Go deeper on NCT06325644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06325644.